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OBJECTIVE—Diabetes increases the risk for microvascular
disease. The retina and the brain both have intricate microvas-
cular systems that are developmentally similar. We sought to
examine whether microvascular lesions in the retina and in the
brain are associated and whether this association differs among
people with and without diabetes.
RESEARCH DESIGN AND METHODS—The analysis in-
cluded 4,218 participants of the Icelandic population-based Age,
Gene/Environment Susceptibility-Reykjavik Study who were
born in 1907–1935 and who were previously followed as a part of
the Reykjavik Study. Retinal focal arteriolar narrowing, arterio-
venous (AV) nicking, and microaneurysms/hemorrhages were
evaluated on digital retinal images of both eyes. Cerebral micro-
bleeds (CMBs) were evaluated from magnetic resonance images.
Data were analyzed with logistic and multinomial logistic regres-
sion models controlling for demographics, major cardiovascular
risk factors, cerebral infarcts, and white matter lesions.
RESULTS—Evidence of brain microbleeds was found in 485
(11.5%) people, including 192 with multiple (2) microbleeds.
Subjects with signs of retinal microvascular lesions were at a
significantly increased likelihood for having multiple CMBs.
People with diabetes in combination with the presence of either
retinal AV nicking (odds ratio [OR] 2.47 [95% CI 1.42–4.31]) or
retinal microaneurysms/hemorrhages (2.28 [1.24–4.18]) were
significantly more likely to have multiple CMBs.
CONCLUSIONS—Retinal microvascular abnormalities and
brain microbleeds may occur together in older adults. People
with both diabetes and signs of retinal microvascular lesions (AV
nicking and microaneurysms/hemorrhages) are more likely to
have multiple microbleeds in the brain. Microvascular disease in
diabetes extends to the brain. Diabetes 57:1645–1650, 2008
Developmentally, the retina is an outgrowth ofthe brain and shares with the brain similarmicrovascular properties in anatomy, physiol-ogy, and metabolic activities (1,2). Microvascu-
lar systems in both the retina and the brain may be affected
by atherosclerotic, hemodynamic, or other metabolic fac-
tors that affect large, small, and microblood vessels (3,4).
Population-based epidemiological studies have shown that
retinal microvascular abnormalities, such as arteriovenous
(AV) nicking, microaneurysms, and hemorrhages, are as-
sociated with an increased risk of clinical stroke and
cerebral white matter lesions (WMLs) (5–8), a marker for
small-vessel disease. To date, no population-based studies
have examined the relation of retinal microvascular signs
to cerebral microbleeds (CMBs), which indicate the pres-
ence of hemorrhagic microvascular lesions or microangi-
opathy in the brain (9). CMBs are histopathologically
confirmed signals on magnetic resonance image (MRI)
that signify hemosiderin deposits due to frank minor
hemorrhages or blood leakage through small blood vessels
(10). Clinical studies suggest that CMBs are associated
with an increased risk for intracerebral hemorrhages and
serve as the basis for a clinical diagnosis of cerebral
amyloid angiopathy (9,11,12).
Individuals with diabetes are known to be at an in-
creased risk for microvascular lesions of both the retina
and the brain. Diabetes also is associated with cognitive
disorders (13–15) and with brain structural changes in
large and small vessels (16,17). Therefore, it is biologically
plausible to hypothesize that the strength of association
between retinal and cerebral microvascular lesions may be
greater in people with diabetes compared with those
without the disease.
In this population-based study of older adults, we
sought to investigate whether retinal microvascular signs
are associated with microbleeds in the brain and whether
the association between retinal microvascular lesions and
brain microbleeds varies by diabetes status.
RESEARCH DESIGN AND METHODS
The study population included all participants of the Icelandic Age, Gene/
Environment Susceptibility (AGES)-Reykjavik Study, a population-based
study aimed to investigate genetic and environmental factors contributing to
diseases of older people. The study design and assessments of the cohort have
been described previously (18). Briefly, the study population of the AGES-
Reykjavik Study consisted of a cohort of men and women born 1907–1935 and
living in the Reykjavik area when the Reykjavik Study (1967–1996) was
launched by the Icelandic Heart Association (IHA). Since the beginning, the
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cohort of the Reykjavik Study has been under surveillance for vital status and
coronary heart disease. From February 2002 to February 2006, survivors of the
original cohort were invited for the AGES-Reykjavik Study, and a total number
of 5,764 subjects participated in the study. The cohort of participants has been
previously described and compared with the total cohort of the AGES-
Reykjavik Study (18).
The AGES-Reykjavik Study has been approved by the Icelandic National
Bioethics Committee (VSN-00-063), which acts as the Institutional Review
Board for the IHA, and by the Institutional Review Board for the U.S. National
Institute on Aging, National Institutes of Health. Written informed consent
was obtained from all participants.
Retinal photography and assessment of retinal microvascular signs.
Two 45-degree digital retinal images, centered on the optic nerve (field 1) and
the macula (field 2), were taken through the pharmacologically dilated pupil
of each of both eyes using a Canon CR6 nonmydriatic camera with a Canon
D60 camera back. The digital retinal images were evaluated for the presence
of retinal microvascular signs by certified graders at the Ocular Epidemiology
Reading Center (Madison, WI) as described previously (19). The retinal
microvascular lesions that were analyzed in this study included focal arterio-
lar narrowing, AV nicking, and signs of retinopathy (microaneurysms and
hemorrhages). The images were evaluated according to standardized proto-
cols using EyeQ Lite image processing software. Graders were masked to
subjects’ health status. In each eye, a grid was placed over the optic nerve that
divided the retina into four distinct quadrants, i.e., superior temporal, superior
nasal, inferior nasal, and inferior temporal. Retinal focal arteriolar narrowing
and AV nicking were assessed in each of the four quadrants, excluding the
area within 1/2 of the disc diameter (zone A). Retinal microvascular signs were
defined as present if the lesion was graded definite or probable in any
quadrant of either eye. Definite focal arteriolar narrowing (in field 1 only) was
graded when the involved vessel was at least 40 m in diameter, or about
one-third of the diameter of a vein at the disc margin, and the constricted area
had a caliber less than or equal to one-half the caliber of proximal and distal
vessel segments. The focal “pinch” had to be at least 250 m in length to be
considered definite. If the grader observed constriction in vessels 40 m in
diameter or if a subtle constriction of vessels was present or a definite pinch
was present but the length was 250 m long, such constriction was graded
as probable focal arteriolar narrowing. When assessing abnormalities of AV
crossings (AV nicking), both fields 1 and 2 were assessed. Crossings within 1/2
DD of the disc margins (zone A) were excluded, as were the atypical crossings
where the venules crossed over the arterioles. Definite AV nicking was defined
as tapering or narrowing of the venular blood column on three or all four sides
of the crossing. If the tapering appeared on only two sides of the crossing, AV
nicking was defined as probable.
For logistical reasons, 4,981 (86.4%) of the 5,764 participants were evalu-
ated with retinal photography for both eyes, and 4,851 (84.2%) had gradable
retinal images for all three measures of retinal microvascular abnormalities.
MRI procedure and definition of CMBs. All eligible participants were
offered a high-resolution MRI examination that was acquired on a 1.5T Signa
Twinspeed system (General Electric Medical Systems, Waukesha, WI). The
image protocol consisted of the following pulse sequences (20): T1-weighted
three-dimensional spoiled gradient-echo sequence (time to echo 8 ms; repe-
tition time 21 ms; flip angle 30°; field of view [FOV] 240 mm; matrix 256 256),
a proton density/T2-weighted fast spin-echo (FSE) sequence (time to echo 1,
22 ms; time to echo 2, 90 ms; repetition time 3,220 ms; echo train length 8; flip
angle 90°; FOV 220 mm; matrix 256  256), and a fluid-attenuated inversion
recovery (FLAIR) sequence (time to echo 100 ms; repetition time 8,000 ms;
inversion time 2,000 ms; flip angle 90°; FOV 220 mm; matrix 256  256). To
detect CMBs, a T2*-weighted gradient-echo type echo planar (GRE-EPI)
sequence (time to echo 50 ms; repetition time 3,050 ms; flip angle 90°; FOV 220
mm; matrix 256  256) sensitive to hemosiderin was used. The acquisition of
these sequences was performed with 3-mm-thick interleaved slices. All images
were acquired to give full brain coverage, and slices were angled parallel to
the anterior-posterior commissure line to give reproducible image views in the
oblique-axial plane.
Two neuroradiologists blinded to subjects’ clinical information assessed
the presence of CMBs on the T2*-weighted GRE-EPI and T2-weighted FSE
images. CMBs were defined as focal areas of signal void within the brain
parenchyma that 1) are visible on T2*-weighted GRE-EPI images, 2) are
smaller or invisible on T2-weighted FSE images (“blooming effect”), 3) are not
abutting a parenchymal defect, and 4) do not show any other structure in the
area of signal void (Fig. 1) (20). Using these criteria, microbleeds can be
differentiated from areas of signal void based on vascular flow voids (which do
not show the “blooming effect”), from past larger hematomas associated with
parenchymal defects, and from cavernomas (which are in general associated
with areas of increased signal on T1- and T2-weighted images within the flow
void). Areas of symmetric hypointensities of the globus pallidus and putamen,
likely to represent calcification or nonhemorrhagic iron deposits, were
excluded.
The presence and number of CMBs and the slice number of each CMB were
assessed and recorded by neuroradiologists. Subsequently, trained raters
accessed the database and recorded the anatomical location and size of each
CMB, up to 30 CMBs. Anatomical locations of CMBs included cerebral lobes
(frontal, parietal, temporal, and occipital), external capsule, basal ganglia
(internal capsule, putamen, globus pallidus, and thalamus), and the infraten-
torium (cerebellum, medulla oblongata, pons, and mesencephalon). Inter-
rater reliability based on MRI readings of 96 participants by two observers was
good (weighted   0.71 and 0.73). Intra-rater reliability based on two ratings
by one observer of the total number of CMBs in 19 brains with a 1-week
interval was excellent (weighted   1) (20).
WMLs were assessed on the T2-weighted FSE and FLAIR images. The WML
load in the subcortical and periventricular areas was separately evaluated
using the previously described scales with known properties (21). A semi-
quantitative estimate of subcortical WMLs was obtained by integrating the
number and size of the lesions: small (3 mm), medium (4–10 mm), and large
(11 mm). A fixed diameter per size category was used to weight each lesion,
and all lesions were summed to get the total score. Periventricular WML load
was rated semiquantitatively by lesion size around frontal caps, parietal caps,
and bands on a scale of 0 (absent), 1 (4 mm), 2 (5–10 mm), and 3 (11 mm)
for the right and left sides of the brain. A high load of subcortical and
periventricular WMLs was defined as being in the highest quartile of the
respective distributions. Cerebral infarcts were evaluated and recorded based
on the T2-weighted FSE/proton density images and the FLAIR images.
Of all 5,764 participants, 5,483 (95.1%) had no contraindications for MRI
scans, and 4,668 (81.0%) had the MRI sequences needed to score CMBs. The
reasons for lack of MRI data on 481 (8.3%) eligible participants were refusal
(n  283) and subjects only participating in home visits (n  198).
Covariates. Data on demographics and other factors potentially related to
both retinal lesions and CMBs were obtained during examination visits to the
study center (18). Global cognitive functioning was assessed with the mini-
mental state examination (MMSE). Current use of medications (e.g., blood
pressure–lowering drugs, antidiabetic drugs, anticoagulants, and aspirin) was
recorded based on presentation of vials at the clinic. Cigarette smoking was
assessed with a standard questionnaire and was dichotomized as current
versus noncurrent (never or former) smokers. Systolic and diastolic (phase V)
blood pressures were measured with a standard mercury sphygmomanome-
ter, and the mean of two measurements on separate occasions was used for
the analysis. Height, weight, fasting blood glucose, and total serum cholesterol
were measured following standard procedures (18,22). BMI was calculated as
measured weight (kg) divided by height squared (m2). Diabetes was ascer-
FIG. 1. CMBs on MRI: signal voids within brain parenchyma that are
not associated with parenchymal defects and do not show any other
structures in the areas of signal voids or focal signal loss on the
T2*-weighted gradient-echo image.
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tained by integrating the information of the self-reported history of diabetes,
use of antidiabetic drugs, or a fasting blood glucose level 7.0 mmol/l (23).
In the analyses, we also controlled for the presence of cerebral infarcts and
severity of subcortical and periventricular WMLs because previous studies
showed that these brain lesions were associated with both retinal microvas-
cular changes and CMBs (6,9,24–26).
Statistical analysis. Of the 5,764 participants, 4,218 (73.2%) with both
gradable retinal photographs and the MRI sequences needed for scoring CMBs
were included in the current analysis. Subjects not included (n  1,546) were
older (79.3 6.5 vs. 76.2 5.4 years [means SD], P 0.001) and more likely
to have diabetes (17.9 vs. 11.1%, age-adjusted P  0.001) and a slightly higher
BMI (27.2  4.7 vs. 27.0  4.3 kg/m2, age-adjusted P  0.001) and to take
anticoagulants or aspirin (34.8 vs. 28.9%, age-adjusted P  0.005); but the two
groups had no significant difference in the distribution of sex, education,
history of smoking, hypertension, serum total cholesterol, and history of using
blood pressure–lowering drugs.
We compared the characteristics of participants with no, a single, and
multiple (2) CMBs by 2 test for categorical variables and by ANOVA for
continuous variables adjusting for age. With logistic regression, we estimated
the odds ratio (OR) and 95% CI of CMBs associated with retinal microvascular
abnormalities. Two-way multiplicative statistical interaction was assessed by
incorporating the independent variables and their cross-product term into the
same model. Multinomial logistic regression analysis was used to examine the
association of retinal microvascular signs with a single and multiple microb-
leeds in the brain. Finally, we assessed the joint additive effect of two factors
(A and B) by specifying their joint exposure status as having neither A nor B
(reference), only A, only B, and both A and B.
We presented the results from two models. The first model was adjusted
for age and sex, and in the second model, additional adjustment was made for
more covariates, as described above, that might explain or modify the
association between retinal microvascular signs and CMBs (10,27). All anal-
yses were completed with the statistical software SPSS 15.0 for Windows
(SPSS, Chicago, IL).
RESULTS
Of the 4,218 subjects, evidence of CMBs was found in 485
(11.5%) people, including 293 (6.9%) with a single CMB and
192 (4.6%) with multiple CMBs. Compared with people
having no CMB, people with a single or multiple CMBs
were older; more often men; more likely to have high
systolic and diastolic pressure, diabetes, cerebral infarcts,
high load of WMLs, cognitive impairment, slightly low total
serum cholesterol, and low BMI; and more likely to use
blood pressure–lowering drugs and anticoagulants/aspirin
(Table 1).
After controlling for demographics and major vascular
factors, the likelihood of having a single CMB (adjusted
OR 0.90 [95% CI 0.61–1.33]) was not higher in people with
diabetes compared with those without diabetes. However,
people with diabetes were significantly more likely to have
multiple CMBs (1.58 [1.04–2.39]) than those without dia-
betes. Diabetes status was not statistically related to
retinal focal arteriolar narrowing and AV nicking but was
significantly associated with retinal microaneurysms/
hemorrhages (multi-adjusted OR 2.32 [1.86–2.89]).
Overall, the presence of CMBs was significantly associ-
ated with retinal AV nicking (multi-adjusted OR 1.29 [95%
CI 1.06–1.57]) and microaneurysms/hemorrhages (1.48
[1.18–1.86]); the association with retinal focal arteriolar
narrowing was statistically marginal (1.25 [0.98–1.60]; P 
0.077). No multiplicative statistical interaction was de-
tected between diabetes status and signs of retinal micro-
vascular lesions on CMBs.
In multinomial logistic regression analysis, focal arterio-
lar narrowing and AV nicking were not significantly asso-
ciated with a single CMB, whereas even controlling for
major potential confounders, signs of both retinal arterio-
lar lesions were significantly associated with a 45%
increased OR for multiple CMBs (Table 2). The presence
of retinal microaneurysms/hemorrhages was marginally
associated with 33% increased likelihood for a single CMB
and significantly associated with 75% increased likelihood
for multiple CMBs (Table 2).
In the analysis of joint additive effect, compared with
subjects with neither diabetes nor microaneurysms/
hemorrhages, individuals having both disorders had a
more than twofold increased likelihood for having multi-
ple CMBs after controlling for multiple potential con-
founders (Table 3). Similarly, people with both diabetes
TABLE 1
Characteristics of study participants (n  4,218) CMBs: the AGES-Reykjavik Study
Characteristics
CMBs
P value*No Single Multiple (2)
n 3,733 293 192
Age (years) 76.0  5.4 77.3  5.2 78.1  5.3 0.001
Systolic BP (mmHg) 141.9  20.2 144.3  19.9 145.4  20.2 0.035
Diastolic BP (mmHg) 73.9  9.6 73.6  9.9 76.4  9.7 0.001
BMI (kg/m2)† 27.0  4.4 26.7  4.1 26.2  3.6 0.070
Fasting blood glucose (mmol/l) 5.8  1.1 5.7  0.9 5.9  1.4 0.191
Total serum cholesterol (mmol/l) 5.6  1.1 5.6  1.3 5.4  1.2 0.015
Female sex 2,206 (59.1) 138 (47.1) 81 (42.2) 0.001
Elementary education† 854 (23.0) 66 (22.8) 49 (25.8) 0.831
Current smoker 448 (12.0) 28 (9.6) 25 (13.0) 0.540
Diabetes 403 (10.8) 33 (11.3) 33 (17.2) 0.013
Use of BP-lowering drugs 2,290 (61.4) 211 (72.0) 136 (71.2) 0.001
Use of anticoagulants/aspirin† 948 (28.1) 90 (32.8) 67 (37.2) 0.012
MMSE score 24 384 (10.3) 35 (11.9) 38 (19.8) 0.011
High subcortical WML load† 851 (22.9) 92 (31.5) 101 (52.6) 0.001
High periventricular WML load† 768 (21.0) 87 (30.4) 92 (49.7) 0.001
Cerebral infarcts 1,044 (28.0) 136 (46.4) 118 (61.5) 0.001
Focal arteriolar narrowing 644 (17.3) 57 (19.5) 49 (25.5) 0.054
AV nicking 1,529 (41.0) 139 (47.4) 104 (54.2) 0.001
Microaneurysms/hemorrhages 687 (18.4) 71 (24.2) 59 (30.7) 0.001
Data are means  SD or n (%). *All P values were adjusted for age. †Information was missing in 4 persons for BMI, in 27 for education, in
394 for anticoagulants or aspirin, in 25 for subcortical WMLs, and in 85 for periventricular WMLs. In subsequent analysis, missing values were
replaced with mean value for continuous variables and with a code of referent group for categorical variables. BP, blood pressure.
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and retinal AV nicking, in comparison with subjects having
neither condition, were significantly more likely to have
multiple CMBs (multi-adjusted OR 2.47 [95% CI 1.42–
4.31]). There appeared to be no joint effect between dia-
betes and focal arteriolar narrowing on CMBs (Table 3).
Because microbleeds in the lobar superficial areas are
more likely to indicate the presence of cerebral amyloid
angiopathy, whereas CMBs in other locations of the brain
more reflect the consequence of hypertension (11,12), we
performed multinomial logistic regression analysis by sep-
arating CMBs in lobar from other areas; the associations
between CMBs and retinal microvascular lesions did not
vary substantially by locations of CMBs (data not shown).
DISCUSSION
In this study of a large community-based cohort of older
adults, we found that retinal focal arteriolar narrowing, AV
nicking, and microaneurysms/hemorrhages were associ-
ated with the presence of multiple microbleeds in the
brain. In particular, people having diabetes together with
retinal AV nicking or microaneurysms/hemorrhages were
more likely to have multiple CMBs. The association was
present independent of major potential confounders, in-
cluding high blood pressure, ischemic brain lesions, and
other vascular factors. These findings are consistent with
the hypothesis that common mechanisms, besides hyper-
tension, are involved in the pathological processes leading
to ocular and cerebral microvascular lesions.
There are several strengths of this study. It was con-
ducted in a large community-based cohort of older men
and women. Retinal microvascular signs were evaluated
following standardized protocols from images directly
acquired from both eyes after pharmacological pupil dila-
tion and without knowledge of subjects’ health status. This
approach improves the ability to detect any retinal lesions
and the reproducibility of grading retinal arteriolar lesions
(3), compared with most previous community-based stud-
ies (3–8), in which only one eye was examined with no
pharmacological pupil dilation.
However, some limitations related to the cross-sectional
design deserve mentioning. First, measures on retinal and
cerebral lesions were taken almost at the same time, and
a temporal relationship cannot be established. Second, the
cross-sectional association may not be generalizable from
this older northern European cohort to populations of
other age or ethnic groups—if these factors affect survival.
Finally, there was a potential for selection bias because
subjects not included in this analysis were older and more
likely to have diabetes than those included. However, if
these individuals were more likely to have retinal lesions
and CMBs, the observed associations are conservative.
Several community-based studies of middle-aged and
older population have shown an association of retinal
microvascular signs, especially microaneurysms/
hemorrhages, with clinical stroke, cerebral infarcts, and
MRI-WMLs (5– 8,24), which are indicators of large and
small-vessel disease in the brain. To the best of our
knowledge, this is the first community-based study to
show an association of signs of retinal arteriolar
changes (i.e., focal narrowing and AV nicking) and
retinopathy lesions (i.e., microaneurysms and hemor-
rhages) with brain microbleeds in an older population.
Furthermore, we found that older people with diabetes,
especially in combination with signs of retinal micro-
vascular lesions, were more likely to have multiple
CMBs. These findings emphasize the importance of
screening for diabetic retinopathy lesions as suggested
in the guidelines (27).
Microvascular lesions in both the retina and the brain
may occur concomitantly as parts of generalized systemic
vascular disease resulting from common pathophysiologi-
cal mechanisms. Retinal focal arteriolar narrowing and AV
nicking are both associated with high blood pressure.
Focal arteriolar narrowing is thought to be a transient
marker for the severity of concurrent hypertension,
whereas retinal AV nicking is thought to be a marker of
damage to the microvasculature from long-standing high
blood pressure (28,29). Therefore, retinal arteriolar signs
and cerebral microvascular disease may reflect the conse-
quence of concurrent and chronic hypertension (1,28–32).
However, when we controlled for high blood pressure, the
associations remained, suggesting that other common
mechanisms may have led to microvascular bleeds in both
the brain and the retina. One such mechanism may be
insulin dysregulation and the subsequent toxic effects that
might have on the brain (33). Advanced glycation end
products may also link microvascular changes in the retina
to those in the brain (34,35). In addition, previous studies
reveal that diabetes is related to cerebral amyloid angiop-
athy, especially among carriers of apolipoprotein E ε4
TABLE 2
Single and multiple microbleeds in the brain related to retinal microvascular signs from multinomial logistic regression models: the
AGES-Reykjavik Study*
Retinal microvascular
abnormalities
Single microbleed Multiple microbleeds
Cases Model 1† Model 2† Cases Model 1† Model 2†
Focal arteriolar narrowing
No 236 1.00 (Reference) 1.00 (Reference) 143 1.00 (Reference) 1.00 (Reference)
Yes 57 1.08 (0.80–1.47) 1.14 (0.83–1.56) 49 1.49 (1.06–2.10) 1.45 (1.01–2.09)
AV nicking
No 154 1.00 (Reference) 1.00 (Reference) 88 1.00 (Reference) 1.00 (Reference)
Yes 139 1.25 (0.98–1.59) 1.22 (0.95–1.55) 104 1.60 (1.19–2.14) 1.44 (1.06–1.95)
Microaneurysms/hemorrhages
No 222 1.00 (Reference) 1.00 (Reference) 133 1.00 (Reference) 1.00 (Reference)
Yes 71 1.35 (1.02–1.78) 1.33 (1.00–1.77) 59 1.82 (1.32–2.51) 1.75 (1.25–2.45)
Data are n or OR (95% CI). *Total n  4,218. Participants with no brain microbleed (n  3,733) held as referent category for multinomial
logistic modeling. †Model 1 was adjusted for age and sex, and in model 2, additional adjustment was made for education, systolic pressure,
diastolic pressure, smoking, diabetes, use of blood pressure lowering drugs, use of anticoagulants/aspirin, total serum cholesterol, cerebral
infarcts, and a heavy load of subcortical and periventricular WMLs.
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allele (13,36), and CMBs are associated with the ε4 allele
(20), suggesting that common genetic susceptibility may
play a role in the association between diabetes and CMBs.
Furthermore, histopathological studies show evidence of
amyloid 	 deposition in the degenerative retina associated
with age-related macular degeneration (37), which has
been linked to retinal microvascular signs (38).
The temporality of these associations needs to be inves-
tigated in longitudinal studies, as does the long-term
physical and cognitive functional implication of combined
cerebral and retinal microvascular lesions (39,40). Finally,
the association of retinal microvascular lesions with CMBs
suggests that additional research is imperative to deter-
mine what the diagnostic implications of retinal assess-
ments are for identifying individuals at risk for cerebral
microvascular lesions and how these associations are
linked to microvascular disease in the kidney and periph-
eral neuropathy.
In summary, this large-scale, community-based study
shows that signs of retinal arteriolar changes and retinop-
athy lesions, such as focal arteriolar narrowing, AV nick-
ing, and retinal microaneurysms/hemorrhages, are
associated with multiple microbleeds in the brain. These
associations appear to be stronger in diabetic people, a
group that is vulnerable to systemic microvascular dis-
ease. This study provides additional evidence of a growing
body of literature on the vulnerability of people with
diabetes to brain changes, most of which have been
demonstrated to have an adverse effect in function.
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